These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21343701)

  • 1. Epigenetic reprogramming as a key contributor to melanocyte malignant transformation.
    Molognoni F; Cruz AT; Meliso FM; Morais AS; Souza CF; Xander P; Bischof JM; Costa FF; Soares MB; Liang G; Jones PA; Jasiulionis MG
    Epigenetics; 2011 Apr; 6(4):450-64. PubMed ID: 21343701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
    de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
    PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis.
    Azevedo H; Pessoa GC; de Luna Vitorino FN; Nsengimana J; Newton-Bishop J; Reis EM; da Cunha JPC; Jasiulionis MG
    Clin Epigenetics; 2020 Aug; 12(1):127. PubMed ID: 32831131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation.
    Molognoni F; de Melo FH; da Silva CT; Jasiulionis MG
    PLoS One; 2013; 8(12):e81937. PubMed ID: 24358134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
    Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
    Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells.
    Mahalingaiah PK; Ponnusamy L; Singh KP
    Oncotarget; 2017 Feb; 8(7):11127-11143. PubMed ID: 27655674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients.
    Papaiz DD; Rius FE; Ayub ALP; Origassa CS; Gujar H; Pessoa DO; Reis EM; Nsengimana J; Newton-Bishop J; Mason CE; Weisenberger DJ; Liang G; Jasiulionis MG
    Mol Oncol; 2022 May; 16(9):1913-1930. PubMed ID: 35075772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation.
    Campos AC; Molognoni F; Melo FH; Galdieri LC; Carneiro CR; D'Almeida V; Correa M; Jasiulionis MG
    Neoplasia; 2007 Dec; 9(12):1111-21. PubMed ID: 18084618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.
    Ricca TI; Liang G; Suenaga AP; Han SW; Jones PA; Jasiulionis MG
    Transl Oncol; 2009 Dec; 2(4):329-40. PubMed ID: 19956395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
    Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
    Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.
    Rius FE; Papaiz DD; Azevedo HFZ; Ayub ALP; Pessoa DO; Oliveira TF; Loureiro APM; Andrade F; Fujita A; Reis EM; Mason CE; Jasiulionis MG
    Clin Epigenetics; 2022 May; 14(1):68. PubMed ID: 35606887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation.
    Severson PL; Tokar EJ; Vrba L; Waalkes MP; Futscher BW
    Epigenetics; 2012 Nov; 7(11):1238-48. PubMed ID: 22976526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
    Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
    BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial nitric oxide synthase uncoupling as a key mediator of melanocyte malignant transformation associated with sustained stress conditions.
    Melo FH; Molognoni F; Morais AS; Toricelli M; Mouro MG; Higa EM; Lopes JD; Jasiulionis MG
    Free Radic Biol Med; 2011 May; 50(10):1263-73. PubMed ID: 21362470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
    Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
    Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocyte transformation associated with substrate adhesion impediment.
    Oba-Shinjo SM; Correa M; Ricca TI; Molognoni F; Pinhal MA; Neves IA; Marie SK; Sampaio LO; Nader HB; Chammas R; Jasiulionis MG
    Neoplasia; 2006 Mar; 8(3):231-41. PubMed ID: 16611417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
    Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
    BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
    Zhao QY; Lei PJ; Zhang X; Zheng JY; Wang HY; Zhao J; Li YM; Ye M; Li L; Wei G; Wu M
    Clin Epigenetics; 2016; 8():34. PubMed ID: 27034728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.